Michael Gelband’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,912
Closed -$368K 2269
2023
Q2
$368K Sell
1,912
-2,688
-58% -$534K ﹤0.01% 1463
2023
Q1
$931K Sell
4,600
-55,881
-92% -$8.96M 0.01% 1163
2022
Q4
$7.77M Buy
60,481
+28,005
+86% +$3.61M 0.11% 233
2022
Q3
$4.44M Sell
32,476
-38,788
-54% -$6.32M 0.06% 449
2022
Q2
$12.6M Buy
71,264
+49,417
+226% +$7.12M 0.15% 145
2022
Q1
$3.15M Sell
21,847
-8,998
-29% -$1.22M 0.04% 573
2021
Q4
$4.77M Buy
30,845
+17,947
+139% +$3M 0.05% 454
2021
Q3
$2.19M Sell
12,898
-20,226
-61% -$3.15M 0.03% 691
2021
Q2
$5.23M Sell
33,124
-32,071
-49% -$4.77M 0.06% 338
2021
Q1
$9.05M Buy
65,195
+37,644
+137% +$6.07M 0.13% 140
2020
Q4
$4.83M Buy
27,551
+15,701
+132% +$2.93M 0.05% 260
2020
Q3
$2.32M Buy
+11,850
New +$1.98M 0.05% 355

Other funds holding SGEN

Michael Gelband's SGEN Position: Q3 2023 in Review

Michael Gelband sold out of Seagen Inc. Common Stock (SGEN) in Q3 2023, closing a stake of 1,912 shares — an estimated $368K sold.

Michael Gelband first reported a position in SGEN in Q3 2020 and held it in 12 quarters. The position peaked at $12.6M in Q2 2022. 616 funds tracked by Wall St. Rank hold SGEN as of Q3 2023.

  • Michael Gelband reported no remaining Seagen Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Michael Gelband sold 1,912 Seagen Inc. Common Stock shares in Q3 2023, an estimated $368K.
  • Michael Gelband first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Michael Gelband's Seagen Inc. Common Stock position peaked at $12.6M in Q2 2022.
  • 616 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2023.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.